2027 Atlantic Regional Hematopathology Meeting:
Future Directions in Hematopathology
REGISTRATION COMING SOON
Advancements in hematopathology based on molecular and genetic information continue to reshape the diagnosis and treatment of hematologic neoplasms. This meeting will highlight the role of molecular pathology and emerging technologies in diagnosis, prognostic stratification, and patient care.
Keynote speakers Eric D. Hsi, MD, Francisco Vega, MD, PhD, and Robert P. Hasserjian, MD will share the latest updates on diagnostic approaches, evolving classifications, and advances in digital pathology, and molecular genetics of hematologic malignancies. Attendees will gain practical insights that can be immediately applied in clinical practice.
Two-Day Program in Collaboration with the Society of Hematopathology
DAY 1: FRIDAY, MAY 14
INNOVATIONS IN EXPERIMENTAL HEMATOPATHOLOGY
Sponsored by the Experimental Hematopathology Committee of the Society of Hematopathology
DATE & TIME: Friday, May 14, 2027 | 12:00 pm – 6:00 pm
LOCATION: Mariott Old City, 1 Dock St., Philadelphia, PA 19106
DAY 2: SATURDAY, MAY 15
2027 ATLANTIC REGIONAL HEMATOPATHOLOGY MEETING:
Future Directions in Hematopathology
DATE & TIME: Saturday, May 15, 2027 | 8:30 am – 3 pm
LOCATION: Marriott Old City, 1 Dock St., Philadelphia, PA 19106
KEYNOTE SPEAKERS FOR SATURDAY, MAY 15th:
Eric D. Hsi, MD
Professor and Chair,
Department of Laboratory
Medicine and Pathology,
Mayo Clinic
Francisco Vega, MD, PhD
Section Head, Hematopathology,
Department of Pathology,
The University of Texas
MD Anderson Cancer Center
Robert P. Hasserjian, MD
Professor of Pathology,
Massachusetts General Hospital
and Harvard Medical School
PROGRAM CO-CHAIRS:
Reza Nejati, MD
Associate Professor
Medical Director of TUHS –
FCCC Clinical Laboratories
Fox Chase Cancer Center
Christopher Y. Park, MD, PhD
Professor,
Department of Pathology at NYU
Grossman School of Medicine
Director, Pathology Education
and Translational Research
ORGANIZING COMMITTEE:
Mariusz A. Wasik, MD
Fox Chase Cancer Center
Robert P. Hasserjian, MD
Massachusetts General Hospital
Henry Chi Hang Fung, MD, FACP, FRCPE
Fox Chase Cancer Center
Kikkeri N. Naresh, MBBS, DCP, MD, FRCPath
Fred Hutch Cancer Center
Peng Ji, MD, PhD
Northwestern University
Mingyi Chen, MD, PhD
UT Southwestern Medical Center
Vinodh Pillai, MD, PhD
University of Pennsylvania.
Nicholas Mackrides, MD
Fox Chase Cancer Center
J. David Peske, MD, PhD
Johns Hopkins University
REGISTRATION FEES: Complimentary registration for all participants includes breakfast, lunch, coffee breaks, and program.
INTENDED AUDIENCE:
Hematopathologists, pathologists of other subspecialties, hematologists/oncologists, radiation oncologists, internists, primary care providers, fellows and residents of pathology, oncology, and other specialties.
CME CREDIT: AMA PRA Category 1 Credit™ will be awarded for participating in the May 15, 2027 meeting
QUESTIONS: Lucía Tono, PhD, JD, MEd
Lucia.Tono-Ramirez@tuhs.temple.edu